Designed to be an ally for your nutritional goals, they’re gluten-free, low-glycemic and keto-friendly with 3 grams of net ...

The 1990s were a decade of change and experimentation, especially concerning diet and health trends. From low-fat crazes to high-protein diets, the '90s saw a wide array of eating plans that promised ...

Pizza, pasta or Chinese take-out used to be the go-to Super Bowl spread for Marla Senzon’s family — until the Florida retiree began taking a GLP-1 appetite-suppressing medication two years ago.

Picture yourself stepping into a dietary landscape where the rules get seriously specific. We're not talking about your ...

The rise of weight-loss drugs is reshaping American eating habits dramatically. Families are swapping heavy Super Bowl snacks ...

The company has outlasted diet fads (Atkins, Keto, Paleo, South Beach), peanut and other recalls and the temptation to over-expand. A typical pattern for a small local company that makes it big is ...

Blockbuster weight-loss drugs are transforming the way we treat obesity. But while costly injectable versions remain out of ...

The Better Business Bureau warns consumers about misleading weight-loss product advertisements. Be wary of exaggerated claims like rapid weight loss without effort, as these are often red flags. Many ...

Picture this: In a dimly lit dive with a co-worker, the bartender asks if you’d like another round. You order another Athletic brew on tap, and your companion ...

Welcome to What’s Up Docs?, the podcast where doctors and identical twins Chris and Xand van Tulleken cut through the confusion around every aspect of our health and wellbeing. In this episode, Chris ...

Roche’s dual GLP-1/GIP receptor agonist has been tied to 22.5% weight loss at 48 weeks, validating the company’s decision to move the asset into phase 3 studies this quarter. The Swiss Big Pharma ...